Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025
key details
| Value | £105,600 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 16 Dec 2024 |
| Contract start | 1 Jan 2025 |
| Contract end | 31 Dec 2025 |
| Procedure | direct |
| SME suitable | No |
| OCID | ocds-b5fd17-65243754-0de9-4191-baae-1f15bfe45303 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Bayer Public Limited Company | £105,600 | 16 Jan 2025 | active |
description
Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo.
Additional information:
Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 24 Jan 2025 | Award (award) | · | c397dcd8-b934-47c9-bcb4-13ac11e4bfd7-820308 |
more from United Lincolnshire Teaching Hospitals NHS Trust
- Accounts Payable Duplicate Payments Software · £99,900 · 29 Jul 2026
- End User Devices · £54,449 · 23 Jul 2026
- Asset Tagging and Verification · £247,810 · 2 Jul 2026
- Childcare Voucher Scheme · £63,744 · 1 Jul 2026
- NOUS insourcing Support · 25 Jun 2026
- Clinical Transcription Service · £137,151 · 22 Jun 2026
- Maintenance - Diagnostic Microscope Equipment ENT Stack (LIDIA009) · £82,726 · 18 Jun 2026
- Operating Model Consultancy Support · £352,030 · 18 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.